Dr. Reddy’s Laboratories issues 3,675 equity shares under ESOPs | Business Upturn

Top Stories

Government increases LPG allocation for industries to 70% of pre-crisis levels; Petroleum Secretary writes to states Iran Rejects US Proposal and Calls Talks a Third Deception — And Now Sirens Are Sounding in Northern Israel Iran Has Responded to the US 15-Point Proposal — Here Are Tehran’s Conditions and Why It Called the Talks a Deception Trump slams NATO for “doing nothing” on Iran, says US needs nothing from allies Viral Video: Internet divided over Priyanka Chopra’s ‘awkward’ interaction with Anne Hathaway and Dua Lipa at Bvlgari Event Iran demands recognition of sovereignty over Strait of Hormuz as ‘legal right’ Setback for Dr Reddy’s as Delhi High Court asks company to halt Olympiq drug sales 11 Airlines Dead in 10 Years — Why India Is One of the Hardest Countries in the World to Run an Airline Government increases LPG allocation for industries to 70% of pre-crisis levels; Petroleum Secretary writes to states Iran Rejects US Proposal and Calls Talks a Third Deception — And Now Sirens Are Sounding in Northern Israel Iran Has Responded to the US 15-Point Proposal — Here Are Tehran’s Conditions and Why It Called the Talks a Deception Trump slams NATO for “doing nothing” on Iran, says US needs nothing from allies Viral Video: Internet divided over Priyanka Chopra’s ‘awkward’ interaction with Anne Hathaway and Dua Lipa at Bvlgari Event Iran demands recognition of sovereignty over Strait of Hormuz as ‘legal right’ Setback for Dr Reddy’s as Delhi High Court asks company to halt Olympiq drug sales 11 Airlines Dead in 10 Years — Why India Is One of the Hardest Countries in the World to Run an Airline

Dr. Reddy’s Laboratories has allotted 3,675 equity shares to eligible employees following the exercise of stock options under its Employees ADR Stock Options Scheme, 2007. The allotment took place on 26 March 2026, with shares issued at a par value of Re.1 each.

Out of the total shares issued, 575 were allocated at an exercise price of Re.1 per share, while the remaining 3,100 shares were issued at an exercise price of ₹735.80 each, attracting a premium of ₹734.80 per share. The shares are fully paid up and rank pari passu with existing shares.

Following this issuance, the total issued share capital of Dr. Reddy’s Laboratories stands at ₹83,46,57,970, comprising 83,46,57,970 equity shares of Re.1 each. The shares are listed on the BSE, NSE, New York Stock Exchange, and NSE IFSC.

Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).

Add us as preferred source on Google

TOPICS: Dr Reddy's Laboratories Equity Shares ESOP Stock Options